Literature DB >> 9403729

Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages.

W F Grashoff1, J K Sont, P J Sterk, P S Hiemstra, W I de Boer, J Stolk, J Han, J M van Krieken.   

Abstract

Chronic obstructive pulmonary disease (COPD) is considered to be caused in part by smoking-induced inflammation, but it is unknown which inflammatory cells within the small airways are associated with the obstruction. We investigated the inflammatory infiltrate in the small airways of 16 current or ex-smokers with COPD (FEV1 < or = 75% predicted) and 15 without COPD (FEV1 > or = 85% predicted) in pneumectomy specimens that were removed for lung cancer. Mast cells, macrophages, neutrophils, eosinophils, T cells, and B cells were identified using immunohistochemistry on formalin-fixed, paraffin-embedded specimens. These cells were quantified in the epithelium and the remainder of the airway wall. The number of mast cells and macrophages in the epithelium, but not in the remainder of the airway wall, was significantly increased in patients with COPD. Neutrophil and T cell numbers did not differ between the groups. Only few B cells and eosinophils were present in both groups. Smoking history, perioperative steroid usage, tumor localization, or reversibility in the FEV1 to salbutamol could not account for the observed differences. We conclude that the number of epithelial mast cells and macrophages is increased in the bronchioli in smokers with airflow limitation, suggesting a role in development of COPD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403729      PMCID: PMC1858350     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

2.  Antileukoprotease-containing bronchiolar cells. Relationship with morphologic disease of small airways and parenchyma.

Authors:  L N Willems; J A Kramps; T Stijnen; P J Sterk; J J Weening; J H Dijkman
Journal:  Am Rev Respir Dis       Date:  1989-05

3.  Pathologic changes in the peripheral airways of young cigarette smokers.

Authors:  D E Niewoehner; J Kleinerman; D B Rice
Journal:  N Engl J Med       Date:  1974-10-10       Impact factor: 91.245

4.  Site and nature of airway obstruction in chronic obstructive lung disease.

Authors:  J C Hogg; P T Macklem; W M Thurlbeck
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

5.  Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers.

Authors:  G W Hunninghake; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-11

6.  The relations between structural changes in small airways and pulmonary-function tests.

Authors:  M Cosio; H Ghezzo; J C Hogg; R Corbin; M Loveland; J Dosman; P T Macklem
Journal:  N Engl J Med       Date:  1978-06-08       Impact factor: 91.245

7.  Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency.

Authors:  D Lamb; A Lumsden
Journal:  Thorax       Date:  1982-05       Impact factor: 9.139

8.  The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction.

Authors:  A Nagai; W W West; W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1985-11

9.  Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa.

Authors:  A Di Stefano; G Turato; P Maestrelli; C E Mapp; M P Ruggieri; A Roggeri; P Boschetto; L M Fabbri; M Saetta
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

10.  Comparison of the cell content of lung lavage fluid with the presence of emphysema and peripheral airways inflammation in resected lungs.

Authors:  J E Hobson; J L Wright; B R Wiggs; J C Hogg
Journal:  Respiration       Date:  1986       Impact factor: 3.580

View more
  33 in total

1.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 2.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Differential distribution of inflammatory cells in large and small airways in smokers.

Authors:  Salvatore Battaglia; Thais Mauad; Annemarie M van Schadewijk; Antonia M Vignola; Klaus F Rabe; Vincenzo Bellia; Peter J Sterk; Pieter S Hiemstra
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

4.  Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung.

Authors:  Antoon Dijkstra; Dirkje S Postma; Jacobien A Noordhoek; Monique E Lodewijk; Henk F Kauffman; Nick H T ten Hacken; Wim Timens
Journal:  Virchows Arch       Date:  2009-03-03       Impact factor: 4.064

Review 5.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 6.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

7.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

8.  Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD.

Authors:  Simona E Budulac; Dirkje S Postma; Pieter S Hiemstra; Lisette I Z Kunz; Mateusz Siedlinski; Henriette A Smit; Judith M Vonk; Bea Rutgers; Wim Timens; H Marike Boezen
Journal:  Respir Res       Date:  2010-05-20

Review 9.  Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease.

Authors:  R Polosa; S Rorke; S T Holgate
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.